Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
posted on
Nov 02, 2020 09:39AM
"Wow! Synergy of apabetalone with SGLT2 inhibitors on renal function and glucose control.....in addition to the MACE data!!! "
So Apabetalone is patent protected till 2040? Is that about right?
Koo